BG102948A - Пиразинони като инхибитори на тромбин - Google Patents

Пиразинони като инхибитори на тромбин Download PDF

Info

Publication number
BG102948A
BG102948A BG102948A BG10294898A BG102948A BG 102948 A BG102948 A BG 102948A BG 102948 A BG102948 A BG 102948A BG 10294898 A BG10294898 A BG 10294898A BG 102948 A BG102948 A BG 102948A
Authority
BG
Bulgaria
Prior art keywords
methyl
mammal
amino
cycloalkyl
alkyl
Prior art date
Application number
BG102948A
Other languages
Bulgarian (bg)
English (en)
Inventor
Philip SANDERSON
Terry Lyle
Bruce Dorsey
Richard Varsolona
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9609714.2A external-priority patent/GB9609714D0/en
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of BG102948A publication Critical patent/BG102948A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG102948A 1996-04-23 1998-11-23 Пиразинони като инхибитори на тромбин BG102948A (bg)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1604196P 1996-04-23 1996-04-23
GBGB9609714.2A GB9609714D0 (en) 1996-05-09 1996-05-09 Pyridinone thrombin inhibitors
US4300997P 1997-04-14 1997-04-14
PCT/US1997/006744 WO1997040024A1 (en) 1996-04-23 1997-04-18 Pyrazinone thrombin inhibitors

Publications (1)

Publication Number Publication Date
BG102948A true BG102948A (bg) 1999-11-30

Family

ID=27268274

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102948A BG102948A (bg) 1996-04-23 1998-11-23 Пиразинони като инхибитори на тромбин

Country Status (21)

Country Link
EP (1) EP0900207B1 (ko)
JP (1) JP3140790B2 (ko)
KR (1) KR20000010650A (ko)
AT (1) ATE209191T1 (ko)
AU (1) AU714985B2 (ko)
BG (1) BG102948A (ko)
BR (1) BR9708859A (ko)
CA (1) CA2252964A1 (ko)
CZ (1) CZ340898A3 (ko)
DE (1) DE69709727T2 (ko)
EE (1) EE9800353A (ko)
HR (1) HRP970211A2 (ko)
IL (1) IL126404A0 (ko)
IS (1) IS4853A (ko)
NO (1) NO984928L (ko)
NZ (1) NZ331993A (ko)
PE (1) PE13399A1 (ko)
PL (1) PL329441A1 (ko)
SK (1) SK145398A3 (ko)
TR (1) TR199802133T2 (ko)
WO (1) WO1997040024A1 (ko)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU746024B2 (en) * 1996-04-23 2002-04-11 Merck & Co., Inc. Pyrazinone thrombin inhibitors
WO1998011075A1 (en) * 1996-09-16 1998-03-19 Du Pont Pharmaceuticals Company Pyrazinones and triazinones and their derivatives thereof
CA2283704A1 (en) * 1997-03-24 1998-10-01 Merck & Co., Inc. Thrombin inhibitors
US6011038A (en) * 1997-09-05 2000-01-04 Merck & Co., Inc. Pyrazinone thrombin inhibitors
US6147078A (en) * 1998-05-19 2000-11-14 Merck & Co., Inc. Pyrazinone thrombin inhibitors
AU753479B2 (en) * 1998-05-19 2002-10-17 Merck & Co., Inc. Pyrazinone thrombin inhibitors
JP2002516326A (ja) * 1998-05-26 2002-06-04 メルク エンド カムパニー インコーポレーテッド イミダゾピリジン系トロンビン阻害薬
DE69926884T2 (de) 1998-06-11 2006-06-14 Johnson & Johnson Pharm Res Pyrazine protease inhibitore
ES2209337T3 (es) * 1998-08-14 2004-06-16 Pfizer Inc. Agentes antitromboticos.
EP1117660A4 (en) * 1998-09-28 2002-01-09 Merck & Co Inc THROMBIN INHIBITORS
EP1124822A4 (en) 1998-10-30 2002-04-03 Merck & Co Inc THROMBIN INHIBITORS
AU752186B2 (en) 1998-10-30 2002-09-12 Merck & Co., Inc. Thrombin inhibitors
WO2000039102A1 (en) 1998-12-23 2000-07-06 Du Pont Pharmaceuticals Company THROMBIN OR FACTOR Xa INHIBITORS
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
US7015230B1 (en) 1999-05-19 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
US6867217B1 (en) 1999-05-19 2005-03-15 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
PL352368A1 (en) * 1999-05-19 2003-08-25 Pharmacia Corp Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
US6750342B1 (en) 1999-05-19 2004-06-15 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
EP1586565A1 (en) * 1999-05-19 2005-10-19 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
US6653316B1 (en) 1999-05-19 2003-11-25 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
US6458952B1 (en) 1999-05-19 2002-10-01 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
US6716838B1 (en) 1999-05-19 2004-04-06 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
US6664255B1 (en) * 1999-05-19 2003-12-16 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
UA58636C2 (uk) * 1999-06-04 2003-08-15 Мерк Енд Ко., Інк. Піразинонові інгібітори тромбіну, фармацевтична композиція, спосіб інгібування утворення тромбів у крові, спосіб лікування станів, пов'язаних із тромбоутворенням
EP1202976B1 (en) 1999-07-19 2006-11-02 Merck Frosst Canada Ltd. Pyrazinones, compositions containing such compounds
AU2044401A (en) 1999-11-23 2001-06-04 Merck & Co., Inc. Pyrazinone thrombin inhibitors
AU2001243598A1 (en) 2000-03-13 2001-09-24 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
EP1267876A1 (en) 2000-03-23 2003-01-02 Merck & Co., Inc. Thrombin inhibitors
CA2405561A1 (en) 2000-04-05 2001-10-18 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
AU2001251315A1 (en) 2000-04-05 2001-10-23 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
US6506760B1 (en) 2000-04-14 2003-01-14 Corvas International, Inc. Substituted hydrazinyl heteroaromatic inhibitors of thrombin
WO2001079193A2 (en) * 2000-04-14 2001-10-25 Corvas International, Inc. Substituted hydrazinyl heteroaromatic inhibitors of thrombin
US6506761B1 (en) 2000-04-14 2003-01-14 Corvas International, Inc. Substituted hydrazinyl heteroaromatic inhibitors of thrombin
US20040171616A9 (en) 2000-04-17 2004-09-02 South Michael S. Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade
AU2001278927A1 (en) * 2000-07-17 2002-01-30 3-Dimensional Pharmaceuticals, Inc. Cyclic oxyguanidine pyrazinones as protease inhibitors
US6710058B2 (en) 2000-11-06 2004-03-23 Bristol-Myers Squibb Pharma Company Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
US7119094B1 (en) 2000-11-20 2006-10-10 Warner-Lambert Company Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade
US7015223B1 (en) 2000-11-20 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade
WO2002042272A2 (en) 2000-11-20 2002-05-30 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
CA2462305A1 (en) 2001-10-03 2003-04-10 Michael S. South 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
CA2462645A1 (en) 2001-10-03 2003-11-13 Pharmacia Corporation Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
EP1490064B1 (en) 2002-02-14 2009-11-18 Pharmacia Corporation Substituted pyridinones as modulators of p38 map kinase
GB0306615D0 (en) * 2003-03-22 2003-04-30 Astrazeneca Ab New use
EP1526131A1 (en) * 2003-10-22 2005-04-27 Graffinity Pharmaceuticals Aktiengesellschaft Aminoalkyl-pyrazinones and -pyridones as thrombin inhibitors
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
EP1893601A1 (en) * 2005-06-17 2008-03-05 AstraZeneca AB Thrombin inhibiting 2-oxo-1, 2, 5, 6-tetrahydropyridine derivatives
CN108271369A (zh) 2015-10-23 2018-07-10 法尔玛赞公司 用于制备色胺及其衍生物的新工艺

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795486A (en) * 1986-09-26 1989-01-03 Boehner Beat Aminopyrazinones and aminotriazinones

Also Published As

Publication number Publication date
IL126404A0 (en) 1999-05-09
CA2252964A1 (en) 1997-10-30
PE13399A1 (es) 1999-02-11
JP2000508334A (ja) 2000-07-04
HRP970211A2 (en) 1998-06-30
KR20000010650A (ko) 2000-02-25
BR9708859A (pt) 1999-08-03
AU2679997A (en) 1997-11-12
DE69709727D1 (de) 2002-02-21
AU714985B2 (en) 2000-01-13
NO984928L (no) 1998-12-22
WO1997040024A1 (en) 1997-10-30
JP3140790B2 (ja) 2001-03-05
CZ340898A3 (cs) 1999-02-17
EP0900207A1 (en) 1999-03-10
NO984928D0 (no) 1998-10-22
IS4853A (is) 1998-09-25
EP0900207B1 (en) 2001-11-21
ATE209191T1 (de) 2001-12-15
TR199802133T2 (xx) 2000-09-21
SK145398A3 (en) 1999-05-07
NZ331993A (en) 2000-04-28
DE69709727T2 (de) 2002-08-08
PL329441A1 (en) 1999-03-29
EE9800353A (et) 1999-04-15

Similar Documents

Publication Publication Date Title
BG102948A (bg) Пиразинони като инхибитори на тромбин
US5866573A (en) Pyrazinone thrombin inhibitors
AU742178B2 (en) Imidazopyridine thrombin inhibitors
WO1999011267A1 (en) Pyrazinone thrombin inhibitors
EP1189899B1 (en) Pyrazinone thrombin inhibitors
AU2044401A (en) Pyrazinone thrombin inhibitors
US6011038A (en) Pyrazinone thrombin inhibitors
US6239132B1 (en) Thrombin inhibitors
US6462050B1 (en) Thrombin inhibitors
US7026324B2 (en) Thrombin inhibitors
US6350745B1 (en) Thrombin inhibitors
US6133297A (en) Thrombin inhibitors
JP2001524522A (ja) トロンビン阻害剤
AU746024B2 (en) Pyrazinone thrombin inhibitors
EP1027333A1 (en) Thrombin inhibitors
WO2002057225A2 (en) Thrombin inhibitors